Extracorporeal photochemotherapy in human and murine graft-versus-host disease.
J Dermatol Sci
; 19(2): 106-13, 1999 Feb.
Article
en En
| MEDLINE
| ID: mdl-10098701
ABSTRACT
Extracorporeal photochemotherapy (ECP) is an immunotherapy that has found a role in the therapy of cutaneous T cell lymphoma, a disease of mature activated T cells. Graft-versus-host disease (GVHD) is also mediated by activated T cells, and thus often responds to therapies that target T cells. Murine models for both GVHD and ECP can be combined to study the impact of this immunotherapy on GVHD. In this paper we present a patient with GVHD who demonstrated a beneficial therapeutic response to treatment with ECP. The findings of this case are compared with the observations from a murine model for GVHD-ECP. The potential mechanisms of ECP in the treatment of GVHD are discussed. along with the similarities observed with ECP in the treatment of other conditions.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad Injerto contra Huésped
Tipo de estudio:
Prognostic_studies
Límite:
Adult
/
Animals
/
Humans
/
Male
Idioma:
En
Año:
1999
Tipo del documento:
Article